Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...